Bavarian Nordic CEO receives "extraordinary" retention bonus

The Covid-19 pandemic has created high demand for executives with vaccine experience, and Bavarian Nordic has chosen to protect its President and CEO Paul Chaplin from poaching attempts by putting some cash aside to keep him in the fold.
Paul Chaplin, CEO at Bavarian Nordic | Photo: Bavarian Nordic
Paul Chaplin, CEO at Bavarian Nordic | Photo: Bavarian Nordic
BY RITZAU, TRANSLATED BY DANIEL PEDERSEN

Bavarian Nordic, which is developing a Covid-19 vaccine, has given its CEO Paul Chaplin a grant of millions of kroner to keep him in the company.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading